Pharmaceutical

MRNA-1365 by Moderna for Human Metapneumovirus Infections: Likelihood of Approval

MRNA-1365 is under clinical development by Moderna and currently in Phase I for Human Metapneumovirus Infections.

May 17, 2024 - 04:00
MRNA-1365 is under clinical development by Moderna and currently in Phase I for Human Metapneumovirus Infections.
Read the original article

Tags:

Previous Article

TT-01488 by TransThera Sciences (Nanjing) for Mantle Cell Lymphoma: Likelihood o...

Next Article

LY-3541860 by Eli Lilly and Co for Relapsing Multiple Sclerosis (RMS): Likelihoo...

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Novaliq and Laboratoires Théa announce EC approval for dry eye disease therapy

Novaliq and Laboratoires Théa announce EC approval for ...

Oct 4, 2024

Karuna Therapeutics files for FDA approval for schizophrenia treatment

Karuna Therapeutics files for FDA approval for schizoph...

Sep 29, 2023

STAT+: Pharmalittle: J&J agrees to settle talcum powder claims for $8.9 billion; FDA authorizes new severe-Covid therapy

STAT+: Pharmalittle: J&J agrees to settle talcum powder...

Apr 5, 2023